PsiQuantum Partners with University of Tokyo and Mitsubishi Chemical for Japanese Workforce Training

PsiQuantum, the University of Tokyo, and Mitsubishi Chemical Corporation have announced a strategic partnership to develop a structured education and training program for Japan’s quantum workforce. The initiative, supported by the Japanese government’s New Energy and Industrial Technology Development Organization (NEDO), focuses on preparing students and professionals for the deployment of fault-tolerant quantum computing. The program aims to bridge the gap between theoretical research and industrial application in sectors such as chemistry and materials science.

The partnership leverages the strengths of each entity: the University of Tokyo leads the academic curriculum, Mitsubishi Chemical provides industrial use cases, and PsiQuantum contributes expertise in fault-tolerant systems and access to Construct, its end-to-end software platform for algorithm design. The initial six-month training program has already enrolled over 80 participants from 20 companies. Over the next two years, the collaboration will expand to include joint R&D projects, specifically investigating how high-chemical-accuracy simulations can be deployed on large-scale photonic quantum systems.

PsiQuantum: Recent Momentum Toward Utility-Scale Systems

This collaboration in Japan is part of a broader global expansion for PsiQuantum as it works to deliver its first utility-scale, million-qubit system:

• Chicago Infrastructure: In late 2025, PsiQuantum broke ground on the Illinois Quantum and Microelectronics Park (IQMP) in Chicago, the site of America’s largest quantum project. The facility will serve as the anchor for the first utility-scale, error-corrected quantum computer.

• NVIDIA Integration: PsiQuantum recently integrated NVIDIA CUDA-Q into its Construct platform, achieving a 450x acceleration in algorithm simulations. This integration allows researchers to optimize fault-tolerant workflows with significant reductions in computational time.

• Healthcare & Industry Partnerships: Beyond the chemical sector, PsiQuantum recently partnered with the National Cancer Center Japan to accelerate drug discovery and has established ongoing collaborations with global leaders like Airbus and Lockheed Martin.

For the official press release on the Japan workforce partnership, visit the PsiQuantum newsroom here. Details on the Illinois Quantum and Microelectronics Park (IQMP) groundbreaking can be found here.

April 16, 2026